Use of Perioperative Intravenous Lidocaine as Part of an Abdominal Surgery Enhanced Recovery Pathway Does Not Significantly Impact Postoperative Pain.

Alison R AlthansBhanu KumpatiDanielle R LavageStephen A EsperKathirvel SubramaniamMichael L BoisenJennifer Holder-Murray

Published in: The American surgeon (2023)

In our study of ERP abdominal surgery patients, perioperative intravenous lidocaine did not offer improvement in postoperative pain scores or OME consumed. We therefore do not recommend the use of intravenous lidocaine as part of an ERP multimodal pain management strategy in abdominal surgery patients.

Keyphrases

postoperative pain
pain management
end stage renal disease
ejection fraction
newly diagnosed
high dose
peritoneal dialysis
patients undergoing
low dose
patient reported outcomes